Search
for
Sort by
Research 181–210 of 1000+
- Mood disorders and quality of life in polycystic ovary syndrome
- Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
- Polycystic Ovary Syndrome
- Obesity and the Polycystic Ovary Syndrome
- Female Adolescent Hair Disorders
- Top Ten List of Clinical Pearls in the Treatment of Acne Vulgaris
- Polycystic ovary syndrome
- Healthy Skin for Women: A Review of Common Conditions and Therapies
- Knowledge and beliefs about the use/abuse of oral contraceptive pills among males: A mixed-method explanatory sequential study in community pharmacy settings
- Clinical and Demographic Characteristics of Patients Diagnosed with Polycystic Ovary Syndrome: A Cross-Sectional Observational Study
- Antidiabetic Management Strategies for Treatment of Polycystic Ovarian Syndrome
- Bicalutamide does not raise transaminases in comparison to alternative anti-androgen regimens among transfeminine adolescents and young adults: a retrospective cohort study
- An Overview of Harmful Effects of Polycystic Ovary Syndrome
- Hair Changes due to Drugs
- Alopecia and drugs
- Das polyzystische Ovarsyndrom: Aktuelle Evidenz und praktische Empfehlungen
- Salivary Inflammatory Markers and Free Androgen Index in Women with Polycystic Ovary Syndrome: A Case-Control Study
- What is the Rationale for Androgen Therapy for Women?
- The Effect of a Very-Low-Calorie Diet (VLCD) vs. a Moderate Energy Deficit Diet in Obese Women with Polycystic Ovary Syndrome (PCOS)—A Randomised Controlled Trial
- Short‐Term, Low‐Dose Spironolactone for Treatment of Hyperandrogenic Symptoms of Polycystic Ovary Syndrome—A Systematic Review
- Effects of Low-Dose Spironolactone Combined with Metformin or Either Drug Alone on Insulin Resistance in Patients with Polycystic Ovary Syndrome: A Pilot Study
- Premature Graying, Balding, and Low Bone Mineral Density in Older Women and Men
- Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review
- Comment on “Androgens and women: COVID‐19 outcomes in women with acne vulgaris, polycystic ovarian syndrome, and hirsutism”
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Association of long-term 5α-reductase inhibitor use with survival in men with renal cell carcinoma: a nationwide population-based cohort study
- Androgen Treatment in Women
- Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database
- Prostate-Sparing Effects in Primates of the Potent Androgen 7α-Methyl-19-Nortestosterone: A Potential Alternative to Testosterone for Androgen Replacement and Male Contraception1
- Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology